Apyx Medical Corporation announced the appointment of Matthew Hill to the position of Chief Financial Officer, effective December 4, 2023. Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023. Mr. Hill joins Apyx Medical from PDS Biotechnology Corporation, where he served as Chief Financial Officer, leading all aspects of the company?s budgeting, forecasting, financial management and reporting.

Prior to joining PDS Biotech, he served as Chief Financial Officer of Strata Skin Sciences from 2018 to 2021. Prior to joining Strata Skin Sciences, Mr. Hill held CFO roles at several companies, including Velcera Inc. and EP MedSystems. He was also a Senior Manager at the international accounting and consulting firm, Grant Thornton LLP. Mr. Hill holds a Bachelor of Science in Accounting from Lehigh University.